About this Journal Submit a Manuscript Table of Contents
International Journal of Alzheimer’s Disease
Volume 2012 (2012), Article ID 731526, 13 pages
http://dx.doi.org/10.1155/2012/731526
Review Article

Structure and Pathology of Tau Protein in Alzheimer Disease

1Laboratory of Biochemistry and Brain Pathophysiology and AD Center, Prague Psychiatric Center, Ústavní 91, 181 03 Prague 8, Czech Republic
2Third Faculty of Medicine, Charles University in Prague, Ruská 87, 100 00 Prague 10, Czech Republic
3Department of Cell Biology, Center of Research and Advanced Studies, National Polytechnic Institute, Avenue Instituto Politecnico Nacional 2508, 07360 Mexico City, DF, Mexico
4Department of Neurology, Third Faculty of Medicine, Faculty Hospital Královské Vinohrady, Charles University in Prague, Šrobárova 50, 100 34 Prague 10, Czech Republic

Received 19 January 2012; Revised 28 March 2012; Accepted 29 March 2012

Academic Editor: David Blum

Copyright © 2012 Michala Kolarova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. B. Maccioni, J. P. Muñoz, and L. Barbeito, “The molecular bases of Alzheimer's disease and other neurodegenerative disorders,” Archives of Medical Research, vol. 32, no. 5, pp. 367–381, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. K. S. Kosik, “The molecular and cellular biology of tau,” Brain Pathology, vol. 3, no. 1, pp. 39–43, 1993. View at Scopus
  3. E. M. Mandelkow, J. Biernat, G. Drewes, N. Gustke, B. Trinczek, and E. Mandelkow, “Tau domains, phosphorylation, and interactions with microtubules,” Neurobiology of Aging, vol. 16, no. 3, pp. 355–363, 1995.
  4. F. Liu, K. Iqbal, I. Grundke-Iqbal, S. Rossie, and C. X. Gong, “Dephosphorylation of tau by protein phosphatase 5: impairment in Alzheimer's disease,” The Journal of Biological Chemistry, vol. 280, no. 3, pp. 1790–1796, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Avila, “Tau kinases and phosphatases: commentary,” Journal of Cellular and Molecular Medicine, vol. 12, no. 1, pp. 258–259, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Iqbal and I. Grundke-Iqbal, “Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention: Alzheimer review series,” Journal of Cellular and Molecular Medicine, vol. 12, no. 1, pp. 38–55, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Sergeant, A. Delacourte, and L. Buée, “Tau protein as a differential biomarker of tauopathies,” Biochimica et Biophysica Acta, vol. 1739, no. 2, pp. 179–197, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. D. W. Cleveland, S. Y. Hwo, and M. W. Kirschner, “Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly,” Journal of Molecular Biology, vol. 116, no. 2, pp. 227–247, 1977. View at Scopus
  9. M. Von Bergen, S. Barghorn, J. Biernat, E. M. Mandelkow, and E. Mandelkow, “Tau aggregation is driven by a transition from random coil to beta sheet structure,” Biochimica et Biophysica Acta, vol. 1739, no. 2, pp. 158–166, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. T. C. Gamblin, “Potential structure/function relationships of predicted secondary structural elements of tau,” Biochimica et Biophysica Acta, vol. 1739, no. 2, pp. 140–149, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Jeganathan, M. Von Bergen, E. M. Mandelkow, and E. Mandelkow, “The natively unfolded character of Tau and its aggregation to Alzheimer-like paired helical filaments,” Biochemistry, vol. 47, no. 40, pp. 10526–10539, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. H. J. Dyson and P. E. Wright, “Intrinsically unstructured proteins and their functions,” Nature Reviews Molecular Cell Biology, vol. 6, no. 3, pp. 197–208, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. D. Mukrasch, S. Bibow, J. Korukottu et al., “Structural polymorphism of 441-residue Tau at single residue resolution,” PLoS Biology, vol. 7, no. 2, Article ID e1000034, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Goedert and R. Jakes, “Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization,” The EMBO Journal, vol. 9, no. 13, pp. 4225–4230, 1990. View at Scopus
  15. A. D. C. Alonso, T. Zaidi, M. Novak, I. Grundke-Iqbal, and K. Iqbal, “Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 12, pp. 6923–6928, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Sergeant, A. Bretteville, M. Hamdane et al., “Biochemistry of Tau in Alzheimer's disease and related neurological disorders,” Expert Review of Proteomics, vol. 5, no. 2, pp. 207–224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Ebneth, R. Godemann, K. Stamer et al., “Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease,” Journal of Cell Biology, vol. 143, no. 3, pp. 777–794, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Couchie, C. Mavilia, I. S. Georgieff, R. K. H. Liem, M. L. Shelanski, and J. Nunez, “Primary structure of high molecular weight tau present in the peripheral nervous system,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 10, pp. 4378–4381, 1992. View at Publisher · View at Google Scholar · View at Scopus
  19. I. S. Georgieff, R. K. H. Liem, D. Couchie, C. Mavilia, J. Nunez, and M. L. Shelanski, “Expression of high molecular weight tau in the central and peripheral nervous systems,” Journal of Cell Science, vol. 105, no. 3, pp. 729–737, 1993. View at Scopus
  20. M. Goedert, M. G. Spillantini, and R. A. Crowther, “Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 5, pp. 1983–1987, 1992. View at Scopus
  21. M. Balastik, J. Lim, L. Pastorino, and K. P. Lu, “Pin1 in Alzheimer's disease: multiple substrates, one regulatory mechanism?” Biochimica et Biophysica Acta, vol. 1772, no. 4, pp. 422–429, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Jung, D. Filliol, M. Miehe, and A. Rendon, “Interaction of brain mitochondria with microtubules reconstituted from brain tubulin and MAP2 or TAU,” Cell Motility and the Cytoskeleton, vol. 24, no. 4, pp. 245–255, 1993. View at Scopus
  23. R. Brandt, J. Léger, and G. Lee, “Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain,” Journal of Cell Biology, vol. 131, no. 5, pp. 1327–1340, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Arrasate, M. Pérez, and J. Avila, “Tau dephosphorylation at Tau-1 site correlates with its association to cell membrane,” Neurochemical Research, vol. 25, no. 1, pp. 43–50, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Maas, J. Eidenmüller, and R. Brandt, “Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments,” The Journal of Biological Chemistry, vol. 275, no. 21, pp. 15733–15740, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. C. H. Reynolds, C. J. Garwood, S. Wray et al., “Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cγ1, Grb2, and Src family kinases,” The Journal of Biological Chemistry, vol. 283, no. 26, pp. 18177–18186, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Baba, K. Akagi, M. Takayanagi, J. G. Flanagan, T. Kobayashi, and M. Hattori, “Fyn tyrosine kinase regulates the surface expression of glycosylphosphatidylinositol-linked ephrin via the modulation of sphingomyelin metabolism,” The Journal of Biological Chemistry, vol. 284, no. 14, pp. 9206–9214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. H. S. Hoe, S. S. Minami, A. Makarova et al., “Fyn modulation of Dab1 effects on amyloid precursor protein and apoe receptor 2 processing,” The Journal of Biological Chemistry, vol. 283, no. 10, pp. 6288–6299, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Lee, R. Thangavel, V. M. Sharma et al., “Phosphorylation of tau by fyn: implications for Alzheimer's disease,” Journal of Neuroscience, vol. 24, no. 9, pp. 2304–2312, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. A. M. Pooler, A. Usardi, C. J. Evans, K. L. Philpott, W. Noble, and D. P. Hanger, “Dynamic association of tau with neuronal membranes is regulated by phosphorylation,” Neurobiology of Aging, vol. 33, no. 2, pp. 431.e27–431.e38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. L. M. Ittner, Y. D. Ke, F. Delerue et al., “Dendritic function of tau mediates amyloid-β toxicity in alzheimer's disease mouse models,” Cell, vol. 142, no. 3, pp. 387–397, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. S. M. Pritchard, P. J. Dolan, A. Vitkus, and G. V. W. Johnson, “The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics,” Journal of Cellular and Molecular Medicine, vol. 15, no. 8, pp. 1621–1635, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. G. P. Cardona-Gómez, C. Arango-Davila, J. C. Gallego-Gómez, A. Barrera-Ocampo, H. Pimienta, and L. M. Garcia-Segura, “Estrogen dissociates Tau and alpha-amino-3-hydroxy-5-methylisoxazole-4- propionic acid receptor subunit in postischemic hippocampus,” NeuroReport, vol. 17, no. 12, pp. 1337–1341, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Klein, E. M. Kramer, A. M. Cardine, B. Schraven, R. Brandt, and J. Trotter, “Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau,” Journal of Neuroscience, vol. 22, no. 3, pp. 698–707, 2002. View at Scopus
  35. R. Brandt and G. Lee, “Functional organization of microtubule-associated protein tau. Identification of regions which affect microtubule growth, nucleation, and bundle formation in vitro,” The Journal of Biological Chemistry, vol. 268, no. 5, pp. 3414–3419, 1993. View at Scopus
  36. J. W. Mandell and G. A. Banker, “A spatial gradient of tau protein phosphorylation in nascent axons,” Journal of Neuroscience, vol. 16, no. 18, pp. 5727–5740, 1996. View at Scopus
  37. D. N. Drechsel, A. A. Hyman, M. H. Cobb, and M. W. Kirschner, “Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau,” Molecular Biology of the Cell, vol. 3, no. 10, pp. 1141–1154, 1992. View at Scopus
  38. K. A. Butner and M. W. Kirschner, “Tau protein binds to microtubules through a flexible array of distributed weak sites,” Journal of Cell Biology, vol. 115, no. 3, pp. 717–730, 1991. View at Publisher · View at Google Scholar · View at Scopus
  39. B. L. Goode and S. C. Feinstein, “Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau,” Journal of Cell Biology, vol. 124, no. 5, pp. 769–781, 1994. View at Scopus
  40. E. Sontag, V. Nunbhakdi-Craig, G. Lee et al., “Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies,” The Journal of Biological Chemistry, vol. 274, no. 36, pp. 25490–25498, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. D. G. Drubin and W. J. Nelson, “Origins of cell polarity,” Cell, vol. 84, no. 3, pp. 335–344, 1996. View at Publisher · View at Google Scholar · View at Scopus
  42. H. V. Goodson, C. Valetti, and T. E. Kreis, “Motors and membrane traffic,” Current Opinion in Cell Biology, vol. 9, no. 1, pp. 18–28, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. C. M. Waterman-Storer and E. D. Salmon, “Microtubule dynamics: treadmilling comes around again,” Current Biology, vol. 7, no. 6, pp. R369–R372, 1997. View at Scopus
  44. S. T. Brady and A. O. Sperry, “Biochemical and functional diversity of microtubule motors in the nervous system,” Current Opinion in Neurobiology, vol. 5, no. 5, pp. 551–558, 1995. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Lippincott-Schwartz, N. B. Cole, A. Marotta, P. A. Conrad, and G. S. Bloom, “Kinesin is the motor for microtubule-mediated Golgi-to-ER membrane traffic,” Journal of Cell Biology, vol. 128, no. 3, pp. 293–306, 1995. View at Publisher · View at Google Scholar · View at Scopus
  46. R. L. Morris and P. J. Hollenbeck, “The regulation of bidirectional mitochondrial transport is coordinated with axonal outgrowth,” Journal of Cell Science, vol. 104, no. 3, pp. 917–927, 1993. View at Scopus
  47. Y. Tanaka, Y. Kanai, Y. Okada et al., “Targeted disruption of mouse conventional kinesin heavy chain, kif5B, results in abnormal perinuclear clustering of mitochondria,” Cell, vol. 93, no. 7, pp. 1147–1158, 1998. View at Publisher · View at Google Scholar · View at Scopus
  48. P. J. Hollenbeck and J. A. Swanson, “Radial extension of macrophage tubular lysosomes supported by kinesin,” Nature, vol. 346, no. 6287, pp. 864–866, 1990. View at Publisher · View at Google Scholar · View at Scopus
  49. E. A. C. Wiemer, T. Wenzel, T. J. Deerinck, M. H. Ellisman, and S. Subramani, “Visualization of the peroxisomal compartment in living mammalian cells: dynamic behavior and association with microtubules,” Journal of Cell Biology, vol. 136, no. 1, pp. 71–80, 1997. View at Publisher · View at Google Scholar · View at Scopus
  50. S. J. Scales, R. Pepperkok, and T. E. Kreis, “Visualization of ER-to-Golgi transport in living cells reveals a sequential mode of action for COPII and COPI,” Cell, vol. 90, no. 6, pp. 1137–1148, 1997. View at Publisher · View at Google Scholar · View at Scopus
  51. I. Cuchillo-Ibanez, A. Seereeram, H. L. Byers et al., “Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin,” The FASEB Journal, vol. 22, no. 9, pp. 3186–3195, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. B. Trinczek, A. Ebneth, E. M. Mandelkow, and E. Mandelkow, “Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles,” Journal of Cell Science, vol. 112, no. 14, pp. 2355–2367, 1999. View at Scopus
  53. R. W. Carrell and B. Gooptu, “Conformational changes and disease–serpins, prions and Alzheimer's,” Current Opinion in Structural Biology, vol. 8, no. 6, pp. 799–809, 1998. View at Publisher · View at Google Scholar · View at Scopus
  54. N. Fox, R. J. Harvey, and M. N. Rossor, “Protein folding, nucleation phenomena and delayed neurodegeneration in Alzheimer's disease,” Reviews in the Neurosciences, vol. 7, no. 1, pp. 21–28, 1996. View at Scopus
  55. B. T. Hyman, J. C. Augustinack, and M. Ingelsson, “Transcriptional and conformational changes of the tau molecule in Alzheimer's disease,” Biochimica et Biophysica Acta, vol. 1739, no. 2, pp. 150–157, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. F. García-Sierra, N. Ghoshal, B. Quinn, R. W. Berry, and L. I. Bínder, “Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 5, no. 2, pp. 65–77, 2003. View at Scopus
  57. N. Ghoshal, F. García-Sierra, Y. Fu et al., “Tau-66: evidence for a novel tau conformation in alzheimer's disease,” Journal of Neurochemistry, vol. 77, no. 5, pp. 1372–1385, 2001. View at Publisher · View at Google Scholar · View at Scopus
  58. N. Ghoshal, F. García-Sierra, J. Wuu et al., “Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease,” Experimental Neurology, vol. 177, no. 2, pp. 475–493, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. E. M. Mandelkow, K. Stamer, R. Vogel, E. Thies, and E. Mandelkow, “Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses,” Neurobiology of Aging, vol. 24, no. 8, pp. 1079–1085, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. N. E. LaPointe, G. Morfini, G. Pigino et al., “The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity,” Journal of Neuroscience Research, vol. 87, no. 2, pp. 440–451, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. A. H. Futerman and G. A. Banker, “The economics of neurite outgrowth–the addition of new membrane to growing axons,” Trends in Neurosciences, vol. 19, no. 4, pp. 144–149, 1996. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Q. Trojanowski and V. M. Y. Lee, “Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases,” The FASEB Journal, vol. 9, no. 15, pp. 1570–1576, 1995. View at Scopus
  63. L. Martin, X. Latypova, and F. Terro, “Post-translational modifications of tau protein: implications for Alzheimer's disease,” Neurochemistry International, vol. 58, no. 4, pp. 458–471, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Soto, “Alzheimer's and prion disease as disorders of protein conformation: implications for the design of novel therapeutic approaches,” Journal of Molecular Medicine, vol. 77, no. 5, pp. 412–418, 1999. View at Publisher · View at Google Scholar · View at Scopus
  65. I. Grundke-Iqbal, K. Iqbal, and Y. C. Tung, “Abnormal phosphorylation of the microtubule-associated protein τ (tau) in Alzheimer cytoskeletal pathology,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 13, pp. 44913–4917, 1986. View at Scopus
  66. S. Mondragón-Rodríguez, G. Basurto-Islas, L. I. Binder, and F. García-Sierra, “Conformational changes and cleavage; are these responsible for the tau aggregation in Alzheimer's disease?” Future Neurology, vol. 4, no. 1, pp. 39–53, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. L. I. Binder, A. L. Guillozet-Bongaarts, F. Garcia-Sierra, and R. W. Berry, “Tau, tangles, and Alzheimer's disease,” Biochimica et Biophysica Acta, vol. 1739, no. 2, pp. 216–223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. B. Kuhla, C. Haase, K. Flach, H. J. Lüth, T. Arendt, and G. Münch, “Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on tau aggregation and filament formation,” The Journal of Biological Chemistry, vol. 282, no. 10, pp. 6984–6991, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. C. M. Wischik, M. Novak, P. C. Edwards, A. Klug, W. Tichelaar, and R. A. Crowther, “Structural characterization of the core of the paired helical filament of Alzheimer disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 13, pp. 4884–4888, 1988. View at Scopus
  70. G. Perry, P. Mulvihill, V. A. Fried, H. T. Smith, I. Grundke-Iqbal, and K. Iqbal, “Immunochemical properties of ubiquitin conjugates in the paired helical filaments of Alzheimer disease,” Journal of Neurochemistry, vol. 52, no. 5, pp. 1523–1528, 1989. View at Scopus
  71. M. R. Reynolds, R. W. Berry, and L. I. Binder, “Site-specific nitration and oxidative dityrosine bridging of the τ protein by peroxynitrite: implications for Alzheimer's disease,” Biochemistry, vol. 44, no. 5, pp. 1690–1700, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. T. C. Gamblin, F. Chen, A. Zambrano et al., “Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 17, pp. 10032–10037, 2003. View at Publisher · View at Google Scholar · View at Scopus
  73. S. W. Min, S. H. Cho, Y. Zhou et al., “Acetylation of tau inhibits its degradation and contributes to tauopathy,” Neuron, vol. 67, no. 6, pp. 953–966, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. L. Buée, T. Bussière, V. Buée-Scherrer, A. Delacourte, and P. R. Hof, “Tau protein isoforms, phosphorylation and role in neurodegenerative disorders,” Brain Research Reviews, vol. 33, no. 1, pp. 95–130, 2000. View at Publisher · View at Google Scholar · View at Scopus
  75. G. Drewes, B. Trinczek, S. Illenberger et al., “Microtubule-associated protein/microtubule affinity-regulating kinase (p110(mark)). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer- specific site serine 262,” The Journal of Biological Chemistry, vol. 270, no. 13, pp. 7679–7688, 1995. View at Publisher · View at Google Scholar · View at Scopus
  76. C. A. Dickey, A. Kamal, K. Lundgren et al., “The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins,” The Journal of Clinical Investigation, vol. 117, no. 3, pp. 648–658, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. C. X. Gong and K. Iqbal, “Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease,” Current Medicinal Chemistry, vol. 15, no. 23, pp. 2321–2328, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. F. Liu, T. Zaidi, K. Iqbal, I. Grundke-Iqbal, R. K. Merkle, and C. X. Gong, “Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease,” FEBS Letters, vol. 512, no. 1–3, pp. 101–106, 2002. View at Publisher · View at Google Scholar · View at Scopus
  79. J. Avila, J. J. Lucas, M. Pérez, and F. Hernández, “Role of tau protein in both physiological and pathological conditions,” Physiological Reviews, vol. 84, no. 2, pp. 361–384, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. E. Kopke, Y. C. Tung, S. Shaikh, C. A. Del Alonso, K. Iqbal, and I. Grundke-Iqbal, “Microtubule-associated protein tau. Abnormal phosphorylation of a non- paired helical filament pool in Alzheimer disease,” The Journal of Biological Chemistry, vol. 268, no. 32, pp. 24374–24384, 1993. View at Scopus
  81. K. Iqbal, F. Liu, C. X. Gong, A. C. del Alonso, and I. Grundke-Iqbal, “Mechanisms of tau-induced neurodegeneration,” Acta Neuropathologica, vol. 118, no. 1, pp. 53–69, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. S. Khatoon, I. Grundke-Iqbal, and K. Iqbal, “Levels of normal and abnormally phosphorylated tan in different cellular and regional compartments of Alzheimer disease and control brains,” FEBS Letters, vol. 351, no. 1, pp. 80–84, 1994. View at Publisher · View at Google Scholar · View at Scopus
  83. A. D. C. Alonso, T. Zaidi, I. Grundke-Iqbal, and K. Iqbal, “Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 12, pp. 5562–5566, 1994. View at Publisher · View at Google Scholar · View at Scopus
  84. B. Li, M. O. Chohan, I. Grundke-Iqbal, and K. Iqbal, “Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau,” Acta Neuropathologica, vol. 113, no. 5, pp. 501–511, 2007. View at Publisher · View at Google Scholar · View at Scopus
  85. J. Z. Wang, C. X. Gong, T. Zaidi, I. Grundke-Iqbal, and K. Iqbal, “Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B,” The Journal of Biological Chemistry, vol. 270, no. 9, pp. 4854–4860, 1995. View at Publisher · View at Google Scholar · View at Scopus
  86. A. D. C. Alonso, I. Grundke-Iqbal, H. S. Barra, and K. Iqbal, “Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 1, pp. 298–303, 1997. View at Scopus
  87. D. P. Hanger, H. L. Byers, S. Wray et al., “Novel phosphorylation sites in Tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis,” The Journal of Biological Chemistry, vol. 282, no. 32, pp. 23645–23654, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. J. Biernat, N. Gustke, G. Drewes, E. M. Mandelkow, and E. Mandelkow, “Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding,” Neuron, vol. 11, no. 1, pp. 153–163, 1993. View at Publisher · View at Google Scholar · View at Scopus
  89. J. T. Du, C. H. Yu, L. X. Zhou et al., “Phosphorylation modulates the local conformation and self-aggregation ability of a peptide from the fourth tau microtubule-binding repeat,” FEBS Journal, vol. 274, no. 19, pp. 5012–5020, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. V. M. Y. Lee, B. J. Balin, L. Otvos, and J. Q. Trojanowski, “A68: a major subunit of paired helical filaments and derivatized forms of normal tau,” Science, vol. 251, no. 4994, pp. 675–678, 1991. View at Scopus
  91. I. Grundke-Iqbal, K. Iqbal, and M. Quinlan, “Microtubule-associated protein tau. A component of Alzheimer paired helical filaments,” The Journal of Biological Chemistry, vol. 261, no. 13, pp. 6084–6089, 1986. View at Scopus
  92. P. V. Arriagada, J. H. Growdon, E. T. Hedley-Whyte, and B. T. Hyman, “Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease,” Neurology, vol. 42, no. 3, pp. 631–639, 1992. View at Scopus
  93. C. Bancher, C. Brunner, H. Lassmann et al., “Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease,” Brain Research, vol. 477, no. 1-2, pp. 90–99, 1989. View at Scopus
  94. E. Braak, H. Braaak, and E. M. Mandelkow, “A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads,” Acta Neuropathologica, vol. 87, no. 6, pp. 554–567, 1994. View at Publisher · View at Google Scholar · View at Scopus
  95. F. García-Sierra, J. J. Hauw, C. Duyckaerts, C. M. Wischik, J. Luna-Muñoz, and R. Mena, “The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old,” Acta Neuropathologica, vol. 100, no. 1, pp. 29–35, 2000. View at Publisher · View at Google Scholar · View at Scopus
  96. K. S. Kosik, C. L. Joachim, and D. J. Selkoe, “Microtubule-associated protein tau (τ) is a major antigenic component of paired helical filaments in Alzheimer disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 11, pp. 4044–4048, 1986. View at Scopus
  97. S. Mondragón-Rodríguez, G. Basurto-Islas, I. Santa-Maria et al., “Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease,” International Journal of Experimental Pathology, vol. 89, no. 2, pp. 81–90, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Saito, G. Chakraborty, R. F. Mao, S. M. Paik, C. Vadasz, and M. Saito, “Tau phosphorylation and cleavage in ethanol-induced neurodegeneration in the developing mouse brain,” Neurochemical Research, vol. 35, no. 4, pp. 651–659, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. T. T. Rohn, R. A. Rissman, M. C. Davis, Y. E. Kim, C. W. Cotman, and E. Head, “Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain,” Neurobiology of Disease, vol. 11, no. 2, pp. 341–354, 2002. View at Publisher · View at Google Scholar · View at Scopus
  100. Q. Zhang, X. Zhang, and A. Sun, “Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models,” Acta Neuropathologica, vol. 117, no. 6, pp. 687–697, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. T. J. Cohen, J. L. Guo, D. E. Hurtado et al., “The acetylation of tau inhibits its function and promotes pathological tau aggregation,” Nature Communications, vol. 2, no. 1, article 252, 2011. View at Publisher · View at Google Scholar · View at Scopus
  102. D. J. Irwin, T. J. Cohen, M. Grossman et al., “Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies,” Brain, vol. 135, no. 3, pp. 807–818, 2012. View at Publisher · View at Google Scholar
  103. C. Choudhary, C. Kumar, F. Gnad et al., “Lysine acetylation targets protein complexes and co-regulates major cellular functions,” Science, vol. 325, no. 5942, pp. 834–840, 2009. View at Publisher · View at Google Scholar · View at Scopus
  104. R. H. Goodman and S. Smolik, “CBP/p300 in cell growth, transformation, and development,” Genes and Development, vol. 14, no. 13, pp. 1553–1577, 2000. View at Scopus
  105. M. C. Haigis and L. P. Guarente, “Mammalian sirtuins–emerging roles in physiology, aging, and calorie restriction,” Genes and Development, vol. 20, no. 21, pp. 2913–2921, 2006. View at Publisher · View at Google Scholar · View at Scopus
  106. S. Michan and D. Sinclair, “Sirtuins in mammals: insights into their biological function,” Biochemical Journal, vol. 404, no. 1, pp. 1–13, 2007. View at Publisher · View at Google Scholar · View at Scopus
  107. L. Gan and L. Mucke, “Paths of convergence: sirtuins in aging and neurodegeneration,” Neuron, vol. 58, no. 1, pp. 10–14, 2008. View at Publisher · View at Google Scholar · View at Scopus
  108. C. Julien, C. Tremblay, V. Émond et al., “Sirtuin 1 reduction parallels the accumulation of tau in alzheimer disease,” Journal of Neuropathology and Experimental Neurology, vol. 68, no. 1, pp. 48–58, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. G. Donmez, D. Wang, D. E. Cohen, and L. Guarente, “SIRT1 suppresses β-amyloid production by activating the α-secretase gene ADAM10,” Cell, vol. 142, no. 2, pp. 320–332, 2010. View at Publisher · View at Google Scholar · View at Scopus
  110. G. C. Ruben, K. Iqbal, I. Grundke-Iqbal, H. M. Wisniewski, T. L. Ciardelli, and J. E. Johnson, “The microtubule-associated protein tau forms a triple-stranded left-hand helical polymer,” The Journal of Biological Chemistry, vol. 266, no. 32, pp. 22019–22027, 1991. View at Scopus
  111. M. Von Bergen, P. Friedhoff, J. Biernat, J. Heberle, E. M. Mandelkow, and E. Mandelkow, “Assembly of τ protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming β structure,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 10, pp. 5129–5134, 2000. View at Scopus
  112. M. Arrasate, M. Pérez, R. Armas-Portela, and J. Ávila, “Polymerization of tau peptides into fibrillar structures. The effect of FTDP-17 mutations,” FEBS Letters, vol. 446, no. 1, pp. 199–202, 1999. View at Publisher · View at Google Scholar · View at Scopus
  113. A. Watanabe, K. Takio, and Y. Ihara, “Deamidation and isoaspartate formation in smeared tau in paired helical filaments: unusual properties of the microtubule-binding domain of tau,” The Journal of Biological Chemistry, vol. 274, no. 11, pp. 7368–7378, 1999. View at Publisher · View at Google Scholar · View at Scopus
  114. R. A. Crowther, O. F. Olesen, R. Jakes, and M. Goedert, “The microtubule binding repeats of tau protein assemble into filaments like those found in Alzheimer's disease,” FEBS Letters, vol. 309, no. 2, pp. 199–202, 1992. View at Publisher · View at Google Scholar · View at Scopus
  115. M. Pérez, J. M. Valpuesta, M. Medina, E. Montejo De Garcini, and J. Avila, “Polymerization of τ into filaments in the presence of heparin: the minimal sequence required for τ-τ interaction,” Journal of Neurochemistry, vol. 67, no. 3, pp. 1183–1190, 1996. View at Scopus
  116. M. Goedert, R. Jakes, M. G. Spillantini, M. Hasegawa, M. J. Smith, and R. A. Crowther, “Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans,” Nature, vol. 383, no. 6600, pp. 550–553, 1996. View at Publisher · View at Google Scholar · View at Scopus
  117. T. Kampers, P. Friedhoff, J. Biernat, E. M. Mandelkow, and E. Mandelkow, “RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments,” FEBS Letters, vol. 399, no. 3, pp. 344–349, 1996. View at Publisher · View at Google Scholar · View at Scopus
  118. D. M. Wilson and L. I. Binder, “Free fatty acids stimulate the polymerization of tau and amyloid β peptides: in vitro evidence for a common effector of pathogenesis in Alzheimer's disease,” American Journal of Pathology, vol. 150, no. 6, pp. 2181–2195, 1997. View at Scopus
  119. S. Barghorn and E. Mandelkow, “Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments,” Biochemistry, vol. 41, no. 50, pp. 14885–14896, 2002. View at Publisher · View at Google Scholar · View at Scopus
  120. T. C. Gamblin, R. W. Berry, and L. I. Binder, “Tau polymerization: role of the amino terminus,” Biochemistry, vol. 42, no. 7, pp. 2252–2257, 2003. View at Publisher · View at Google Scholar · View at Scopus
  121. J. Kuret, C. N. Chirita, E. E. Congdon et al., “Pathways of tau fibrillization,” Biochimica et Biophysica Acta, vol. 1739, no. 2, pp. 167–178, 2005. View at Publisher · View at Google Scholar · View at Scopus
  122. M. E. King, T. C. Gamblin, J. Kuret, and L. I. Binder, “Differential assembly of human tau isoforms in the presence of arachidonic acid,” Journal of Neurochemistry, vol. 74, no. 4, pp. 1749–1757, 2000. View at Publisher · View at Google Scholar · View at Scopus
  123. K. R. Patterson, C. Remmers, Y. Fu et al., “Characterization of prefibrillar tau oligomers in vitro and in Alzheimer disease,” The Journal of Biological Chemistry, vol. 286, no. 26, pp. 23063–23076, 2011. View at Publisher · View at Google Scholar · View at Scopus
  124. K. Santacruz, J. Lewis, T. Spires et al., “Medicine: tau suppression in a neurodegenerative mouse model improves memory function,” Science, vol. 309, no. 5733, pp. 476–481, 2005. View at Publisher · View at Google Scholar · View at Scopus
  125. A. Sydow, A. Van Der Jeugd, F. Zheng et al., “Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic tau mutant,” Journal of Neuroscience, vol. 31, no. 7, pp. 2511–2525, 2011. View at Publisher · View at Google Scholar · View at Scopus
  126. Z. Berger, H. Roder, A. Hanna et al., “Accumulation of pathological tau species and memory loss in a conditional model of tauopathy,” Journal of Neuroscience, vol. 27, no. 14, pp. 3650–3662, 2007. View at Publisher · View at Google Scholar · View at Scopus
  127. C. M. Wischik, M. Novak, H. C. Thogersen et al., “Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 12, pp. 4506–4510, 1988. View at Scopus
  128. M. Novak, J. Kabat, and C. M. Wischik, “Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament,” The EMBO Journal, vol. 12, no. 1, pp. 365–370, 1993. View at Scopus
  129. R. Mena, P. C. Edwards, C. R. Harrington, E. B. Mukaetova-Ladinska, and C. M. Wischik, “Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease,” Acta Neuropathologica, vol. 91, no. 6, pp. 633–641, 1996. View at Publisher · View at Google Scholar · View at Scopus
  130. F. García-Sierra, C. M. Wischik, C. R. Harrington, J. Luna-Muñoz, and R. Mena, “Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease,” Journal of Chemical Neuroanatomy, vol. 22, no. 1-2, pp. 65–77, 2001. View at Publisher · View at Google Scholar · View at Scopus
  131. A. Abraha, N. Ghoshal, T. C. Gamblin et al., “C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease,” Journal of Cell Science, vol. 113, no. 21, pp. 3737–3745, 2000. View at Scopus
  132. T. T. Rohn, R. A. Rissman, E. Head, and C. W. Cotman, “Caspase activation in the Alzheimer's disease brain: tortuous and torturous,” Drug News and Perspectives, vol. 15, no. 9, pp. 549–557, 2002. View at Publisher · View at Google Scholar · View at Scopus
  133. S. M. De La Monte, Y. K. Sohn, and J. R. Wands, “Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease,” Journal of the Neurological Sciences, vol. 152, no. 1, pp. 73–83, 1997. View at Publisher · View at Google Scholar · View at Scopus
  134. C. Stadelmann, T. L. Deckwerth, A. Srinivasan et al., “Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease: evidence for apoptotic cell death,” American Journal of Pathology, vol. 155, no. 5, pp. 1459–1466, 1999. View at Scopus
  135. T. T. Rohn, E. Head, J. H. Su et al., “Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease,” American Journal of Pathology, vol. 158, no. 1, pp. 189–198, 2001. View at Scopus
  136. Z. Nagy and M. M. Esiri, “Apoptosis-related protein expression in the hippocampus in Alzheimer's disease,” Neurobiology of Aging, vol. 18, no. 6, pp. 565–571, 1997. View at Publisher · View at Google Scholar · View at Scopus
  137. H. Guo, S. Albrecht, M. Bourdeau, T. Petzke, C. Bergeron, and A. C. LeBlanc, “Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease,” American Journal of Pathology, vol. 165, no. 2, pp. 523–531, 2004. View at Scopus
  138. J. H. Su, M. Zhao, A. J. Anderson, A. Srinivasan, and C. W. Cotman, “Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology,” Brain Research, vol. 898, no. 2, pp. 350–357, 2001. View at Publisher · View at Google Scholar · View at Scopus
  139. V. Cryns and J. Yuan, “Proteases to die for,” Genes and Development, vol. 12, no. 11, pp. 1551–1570, 1998. View at Scopus
  140. F. G. Gervais, D. Xu, G. S. Robertson et al., “Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-β precursor protein and amyloidogenic Aβ peptide formation,” Cell, vol. 97, no. 3, pp. 395–406, 1999. View at Scopus
  141. G. Smale, N. R. Nichols, D. R. Brady, C. E. Finch, and W. E. Horton, “Evidence for apoptotic cell death in Alzheimer's disease,” Experimental Neurology, vol. 133, no. 2, pp. 225–230, 1995. View at Publisher · View at Google Scholar · View at Scopus
  142. R. A. Rissman, W. W. Poon, M. Blurton-Jones et al., “Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology,” The Journal of Clinical Investigation, vol. 114, no. 1, pp. 121–130, 2004. View at Publisher · View at Google Scholar · View at Scopus
  143. C. W. Cotman, W. W. Poon, R. A. Rissman, and M. Blurton-Jones, “The role of caspase cleavage of tau in Alzheimer disease neuropathology,” Journal of Neuropathology and Experimental Neurology, vol. 64, no. 2, pp. 104–112, 2005. View at Scopus
  144. R. W. Berry, A. Abraha, S. Lagalwar et al., “Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment,” Biochemistry, vol. 42, no. 27, pp. 8325–8331, 2003. View at Publisher · View at Google Scholar · View at Scopus
  145. A. L. Guillozet-Bongaarts, F. Garcia-Sierra, M. R. Reynolds et al., “Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease,” Neurobiology of Aging, vol. 26, no. 7, pp. 1015–1022, 2005. View at Publisher · View at Google Scholar · View at Scopus
  146. A. L. Guillozet-Bongaarts, M. E. Cahill, V. L. Cryns, M. R. Reynolds, R. W. Berry, and L. I. Binder, “Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo,” Journal of Neurochemistry, vol. 97, no. 4, pp. 1005–1014, 2006. View at Publisher · View at Google Scholar · View at Scopus
  147. P. M. Horowitz, K. R. Patterson, A. L. Guillozet-Bongaarts et al., “Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease,” Journal of Neuroscience, vol. 24, no. 36, pp. 7895–7902, 2004. View at Publisher · View at Google Scholar · View at Scopus
  148. B. Bandyopadhyay, G. Li, H. Yin, and J. Kuret, “Tau aggregation and toxicity in a cell culture model of tauopathy,” The Journal of Biological Chemistry, vol. 282, no. 22, pp. 16454–16464, 2007. View at Publisher · View at Google Scholar · View at Scopus
  149. N. Canu, L. Dus, C. Barbato et al., “Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis,” Journal of Neuroscience, vol. 18, no. 18, pp. 7061–7074, 1998. View at Scopus
  150. L. Fasulo, M. Ovecka, J. Kabat, A. Bradbury, M. Novak, and A. Cattaneo, “Overexpression of Alzheimer's PHF core tau fragments: implications for the tau truncation hypothesis,” Alzheimer's Research, vol. 2, no. 5, pp. 195–200, 1996. View at Scopus
  151. L. Fasulo, G. Ugolini, M. Visintin et al., “The neuronal microtubule-associated protein tau is a substrate for caspase-3 and an effector of apoptosis,” Journal of Neurochemistry, vol. 75, no. 2, pp. 624–633, 2000. View at Publisher · View at Google Scholar · View at Scopus
  152. L. Fasulo, G. Ugolini, and A. Cattaneo, “Apoptotic effect of caspase-3 cleaved tau in hippocampal neurons and its potentiation by tau FTDP-mutation N279K,” Journal of Alzheimer's Disease, vol. 7, no. 1, pp. 3–13, 2005. View at Scopus
  153. W. Chun and G. V. W. Johnson, “The role of tau phosphorylation and cleavage in neuronal cell death,” Frontiers in Bioscience, vol. 12, no. 2, pp. 733–756, 2007. View at Publisher · View at Google Scholar · View at Scopus
  154. T. A. Matthews-Roberson, R. A. Quintanilla, H. Ding, and G. V. W. Johnson, “Immortalized cortical neurons expressing caspase-cleaved tau are sensitized to endoplasmic reticulum stress induced cell death,” Brain Research, vol. 1234, no. C, pp. 206–212, 2008. View at Publisher · View at Google Scholar · View at Scopus
  155. R. A. Quintanilla, T. A. Matthews-Roberson, P. J. Dolan, and G. V. W. Johnsion, “Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of alzheimer disease,” The Journal of Biological Chemistry, vol. 284, no. 28, pp. 18754–18766, 2009. View at Publisher · View at Google Scholar · View at Scopus
  156. R. A. Quintanilla, P. J. Dolan, Y. N. Jin, and G. V. W. Johnson, “Truncated tau and Aβ cooperatively impair mitochondria in primary neurons,” Neurobiology of Aging, vol. 33, no. 3, pp. 619.e25–619.e35, 2012. View at Publisher · View at Google Scholar · View at Scopus
  157. P. Filipcik, M. Cente, G. Krajciova, I. Vanicky, and M. Novak, “Cortical and hippocampal neurons from truncated tau transgenic rat express multiple markers of neurodegeneration,” Cellular and Molecular Neurobiology, vol. 29, no. 6-7, pp. 895–900, 2009. View at Publisher · View at Google Scholar · View at Scopus
  158. P. Delobel, I. Lavenir, G. Fraser et al., “Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy,” American Journal of Pathology, vol. 172, no. 1, pp. 123–131, 2008. View at Publisher · View at Google Scholar · View at Scopus
  159. A. De Calignon, L. M. Fox, R. Pitstick et al., “Caspase activation precedes and leads to tangles,” Nature, vol. 464, no. 7292, pp. 1201–1204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  160. P. Koson, N. Zilka, A. Kovac et al., “Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load,” European Journal of Neuroscience, vol. 28, no. 2, pp. 239–246, 2008. View at Publisher · View at Google Scholar · View at Scopus
  161. M. Cente, P. Filipcik, M. Pevalova, and M. Novak, “Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy,” European Journal of Neuroscience, vol. 24, no. 4, pp. 1085–1090, 2006. View at Publisher · View at Google Scholar · View at Scopus
  162. P. J. McMillan, B. C. Kraemer, L. Robinson, J. B. Leverenz, M. Raskind, and G. Schellenberg, “Truncation of tau at E391 promotes early pathologic changes in transgenic mice,” Journal of Neuropathology and Experimental Neurology, vol. 70, no. 11, pp. 1006–1019, 2011. View at Publisher · View at Google Scholar
  163. G. Basurto-Islas, J. Luna-Muñoz, A. L. Guillozet-Bongaarts, L. I. Binder, R. Mena, and F. García-Sierra, “Accumulation of aspartic acid421- and glutamic acid 391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease,” Journal of Neuropathology and Experimental Neurology, vol. 67, no. 5, pp. 470–483, 2008. View at Publisher · View at Google Scholar · View at Scopus
  164. H. Braak and E. Braak, “Neuropathological stageing of Alzheimer-related changes,” Acta Neuropathologica, vol. 82, no. 4, pp. 239–259, 1991. View at Scopus
  165. F. García-Sierra, J. J. Jarero-Basulto, Z. Kristofikova, E. Majer, L. I. Binder, and D. Ripova, “Ubiquitin is associated with early truncation of tau protein at aspartic acid421 during the maturation of neurofibrillary tangles in Alzheimer's disease,” Brain Pathology, vol. 22, no. 2, pp. 240–250, 2012. View at Publisher · View at Google Scholar
  166. F. García-Sierra, S. Mondragón-Rodríguez, and G. Basurto-Islas, “Truncation of tau protein and its pathological significance in Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 14, no. 4, pp. 401–409, 2008. View at Scopus